P0DTD1 (R1AB_SARS2) Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
Replicase polyprotein 1ab UniProtKBInterProInteractive Modelling
7096 aa; Sequence (Fasta) Identical sequences: Severe acute respiratory syndrome coronavirus 2: A0A679G4D8; A0A6B9V049; A0A6V7ALW7
Molecule Processing
| Host translation inhibitor nsp1 | |
| Non-structural protein 2 | |
| Non-structural protein 3 | |
| Non-structural protein 4 | |
| 3C-like proteinase | |
| Non-structural protein 6 | |
| Non-structural protein 7 | |
| Non-structural protein 8 | |
| Non-structural protein 9 | |
| Non-structural protein 10 | |
| RNA-directed RNA polymerase | |
| Helicase | |
| Proofreading exoribonuclease | |
| Uridylate-specific endoribonuclease | |
| 2'-O-methyltransferase |
Sequence Features
| 1674 | For PL1-PRO activity | ||
| 1835 | For PL2-PRO activity | ||
| 3304 | For 3CL-PRO activity | ||
| 3408 | Nucleophile; for 3CL-PRO activity | ||
| 4687 | Zinc 1; structural | ||
| 4693 | Zinc 1; structural | ||
| 4698 | Zinc 1; structural | ||
| 4702 | Zinc 1; structural | ||
| 4879 | Zinc 2; structural | ||
| 5034 | Zinc 2; structural | ||
| 5037 | Zinc 2; structural | ||
| 5038 | Zinc 2; structural | ||
| 5329 | Zinc 3 | ||
| 5332 | Zinc 3 | ||
| 5340 | Zinc 4 | ||
| 5343 | Zinc 3 | ||
| 5350 | Zinc 3 | ||
| 5353 | Zinc 4; via tele nitrogen | ||
| 5357 | Zinc 4; via pros nitrogen | ||
| 5363 | Zinc 4 | ||
| 5374 | Zinc 5 | ||
| 5379 | Zinc 5; via pros nitrogen | ||
| 5396 | Zinc 5 | ||
| 5399 | Zinc 5 | ||
| 2226-2246 | Helical | ||
| 2318-2338 | Helical | ||
| 2776-2796 | Helical | ||
| 3045-3065 | Helical | ||
| 3100-3120 | Helical | ||
| 3128-3148 | Helical | ||
| 3587-3607 | Helical | ||
| 3609-3629 | Helical | ||
| 3635-3655 | Helical | ||
| 3674-3694 | Helical | ||
| 3730-3750 | Helical | ||
| 3779-3799 | Helical | ||
| 1752-1789 | C4-type | ||
| 5606-5613 | NTP | ||
| 180-181 | Cleavage; by PL-PRO | ||
| 818-819 | Cleavage; by PL-PRO | ||
| 2763-2764 | Cleavage; by PL-PRO | ||
| 3263-3264 | Cleavage; by 3CL-PRO | ||
| 3569-3570 | Cleavage; by 3CL-PRO | ||
| 3859-3860 | Cleavage; by 3CL-PRO | ||
| 3942-3943 | Cleavage; by 3CL-PRO | ||
| 4140-4141 | Cleavage; by 3CL-PRO | ||
| 4253-4254 | Cleavage; by 3CL-PRO | ||
| 4392-4393 | Cleavage; by 3CL-PRO | ||
| 5324-5325 | Cleavage; by 3CL-PRO | ||
| 5925-5926 | Cleavage; by 3CL-PRO | ||
| 6452-6453 | Cleavage; by 3CL-PRO | ||
| 6798-6799 | Cleavage; by 3CL-PRO | ||
| 9-143 | Non-structural protein NSP1, betacoronavirus IPR021590PF11501 | ||
| 183-423 | Coronavirus replicase NSP2, N-terminal IPR043615PF19211 | ||
| 652-818 | Coronavirus replicase NSP2, C-terminal IPR043613PF19212 | ||
| 880-1050 | Non-structural protein NSP3, N-terminal, betacoronavirus IPR024358PF12379 | ||
| 1058-1164 | Macro domain IPR002589PF01661 | ||
| 1351-1493 | Non-structural protein NSP3, single-stranded poly(A) binding domain, betacoronavirus IPR024375PF11633 | ||
| 1498-1561 | DPUP/SUD, C-terminal, betacoronavirus IPR022733PF12124 | ||
| 1564-1882 | Peptidase C16, coronavirus IPR013016PF08715 | ||
| 1922-2019 | Non-structural protein NSP3, nucleic acid-binding (NAR) domain, betacoronavirus IPR032592PF16251 | ||
| 2261-2748 | Coronavirus replicase NSP3, C-terminal IPR043611PF19218 | ||
| 2788-3141 | Coronavirus replicase NSP4, N-terminal IPR043612PF19217 | ||
| 3166-3261 | Non-structural protein NSP4, C-terminal, coronavirus IPR032505PF16348 | ||
| 3292-3582 | Peptidase C30, coronavirus IPR008740PF05409 | ||
| 3598-3859 | Coronavirus replicase NSP6 IPR043610PF19213 | ||
| 3860-3942 | Non-structural protein NSP7, coronavirus IPR014828PF08716 | ||
| 3943-4139 | Non-structural protein NSP8, coronavirus-like IPR014829PF08717 | ||
| 4141-4253 | Non-structural protein NSP9, coronavirus IPR014822PF08710 | ||
| 4262-4384 | RNA synthesis protein NSP10, coronavirus IPR018995PF09401 | ||
| 4407-4758 | RNA polymerase, N-terminal, coronaviral IPR009469PF06478 | ||
| 4792-5280 | RNA-directed RNA polymerase, C-terminal domain IPR001205PF00680 | ||
| 5672-5896 | (+) RNA virus helicase core domain IPR027351PF01443 | ||
| 5929-6450 | Non-structural protein NSP14, coronavirus IPR009466PF06471 | ||
| 6453-6513 | Coronavirus replicase NSP15, N-terminal oligomerisation IPR043606PF19219 | ||
| 6523-6619 | Coronavirus replicase NSP15, middle domain IPR043608PF19216 | ||
| 6644-6796 | Coronavirus replicase NSP15, uridylate-specific endoribonuclease IPR043609PF19215 | ||
| 6800-7095 | Non-structural protein NSP16, coronavirus-like IPR009461PF06460 |
Sequence Alignments
Host translation inhibitor nsp1 1-180; PRO_0000449619
| Oligo-state | Ligands | QMEAN | Template | Range | Seq id (%) |
|---|---|---|---|---|---|
| monomer | -4.01 | 2hsx.1.A | 86.09 | ||
| Assess | |||||
Non-structural protein 3 819-2763; PRO_0000449621
| Description | Oligo-state | Ligands | Structure | Range | |
|---|---|---|---|---|---|
| SARS CoV-2 PLpro in complex with ISG15 C-terminal domain propargylamide |
Heteromer P05161; | 3×GOL; 1×ZN; | 6xa9 | ||
| Assess | |||||
| SARS CoV-2 PLpro in complex with ubiquitin propargylamide |
Heteromer P0CG47; | 1×ZN; | 6xaa | ||
| Assess | |||||
| PLpro-C111S with mISG15 |
Heteromer Q64339; | 1×ZN; | 6yva | ||
| Assess | |||||
| Crystal structure of the SARS-CoV-2 PLpro C111S mutant | homo-4-mer | 4×ZN; 1×EDO; | 7cjd | ||
| Assess | |||||
| The crystal structure of papain-like protease of SARS CoV-2 | homo-3-mer | 4×ZN; 3×CL; | 6w9c | ||
| Assess | |||||
| The crystal structure of Papain-Like Protease of SARS CoV-2 , C111S mutant, at room temperature | homo-2-mer | 2×ZN; 2×PO4; 2×CL; | 6xg3 | ||
| Assess | |||||
| Crystal structure of the ubiquitin-like domain 1 (Ubl1) of Nsp3 from SARS-CoV-2 | homo-2-mer | 13×EDO; 1×SO4; | 7kag | ||
| Assess | |||||
| Crystal structure of the SARS CoV-2 Papain-like protease in complex with peptide inhibitor VIR250 | monomer | 1×ZN; | 6wuu | ||
| Assess | |||||
| Crystal structure of the SARS CoV-2 Papain-like protease in complex with peptide inhibitor VIR251 | monomer | 1×ZN; | 6wx4 | ||
| Assess | |||||
| The crystal structure of Papain-Like Protease of SARS CoV-2 , C111S mutant | monomer | 1×ZN; 3×PO4; 2×CL; 2×GOL; | 6wrh | ||
| Assess | |||||
| The crystal structure of Papain-Like Protease of SARS CoV-2 , P3221 space group | monomer | 1×ZN; 2×GOL; 2×PO4; 2×CL; | 6wzu | ||
| Assess | |||||
| Crystal structure of the wild type SARS-CoV-2 papain-like protease (PLPro) with inhibitor GRL0617 | monomer | 1×TTT; 1×ZN; 2×SO4; | 7jrn | ||
| Assess | |||||
| Crystal structure of the SARS-CoV-2 PLpro with GRL0617 | monomer | 1×TTT; 2×ZN; | 7cmd | ||
| Assess | |||||
| SARS CoV-2 PLpro in complex with GRL0617 | monomer | 1×TTT; 3×ZN; | 7cjm | ||
| Assess | |||||
| The crystal structure of Papain-Like Protease of SARS CoV-2 , C111S mutant, in complex with PLP_Sny… | monomer | 1×Y95; 4×ZN; 3×CL; 1×MES; 2×ACT; | 7jit | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 Papain-like protease C111S | monomer | 1×ZN; 1×CA; | 7d47 | ||
| Assess | |||||
| The crystal structure of Papain-Like Protease of SARS CoV-2 , C111S mutant, in complex with PLP_Sny… | monomer | 1×TTT; 4×ZN; 4×CL; 1×MES; 1×ACT; | 7jir | ||
| Assess | |||||
| The crystal structure of Papain-Like Protease of SARS CoV-2 in complex with PLP_Snyder441 | monomer | 1×Y41; 5×ZN; 4×CL; 1×ACT; 5×UNX; | 7jn2 | ||
| Assess | |||||
| The crystal structure of Papain-Like Protease of SARS CoV-2 , C111S mutant, in complex with PLP_Sny… | monomer | 1×VBY; 4×ZN; 1×MES; 3×CL; 1×ACT; | 7jiv | ||
| Assess | |||||
| The crystal structure of Papain-Like Protease of SARS CoV-2 in complex with PLP_Snyder530 | monomer | 1×VBY; 4×ZN; 4×CL; 1×MES; | 7jiw | ||
| Assess | |||||
| SARS-CoV-2 Macrodomain in complex with ADP-ribose | monomer | 1×APR; 1×NA; | 6z5t | ||
| Assess | |||||
| SARS-CoV-2 Macrodomain in complex with ADP-HPM | monomer | 1×A3R; 3×EDO; 1×NA; | 6z72 | ||
| Assess | |||||
| SARS-CoV-2 Macrodomain in complex with ADP-HPD | monomer | 2×A1R; 3×EDO; 1×GOL; 2×NA; | 6z6i | ||
| Assess | |||||
| High-resolution structure of the SARS-CoV-2 NSP3 Macro X domain | monomer | 6wey | |||
| Assess | |||||
| Crystal structure of SARS-CoV-2 (Covid-19) NSP3 macrodomain in complex with MES | monomer | 1×MES; 5×EDO; | 6ywm | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain (C2 crystal form, 100 K) | monomer | 7kr0 | |||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain (C2 crystal form, methylated) | monomer | 7kqw | |||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000157088 | monomer | 1×HBD; | 5rvm | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 macrodomain in complex with GMP | monomer | 1×5GP; 9×EDO; | 7bf4 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 macrodomain in complex with adenosine | monomer | 3×EDO; 1×ADN; | 7bf3 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 macrodomain in complex with ADP-ribose-phosphate (ADP-ribose-2'-pho… | monomer | 1×MG; 1×A2R; 2×EDO; | 7bf5 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 macrodomain in complex with remdesivir metabolite GS-441524 | monomer | 1×F86; 3×EDO; | 7bf6 | ||
| Assess | |||||
| Structure of the SARS-CoV-2 macrodomain (NSP3) in complex with ADP-ribose | monomer | 1×APR; | 6woj | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 (Covid-19) NSP3 macrodomain in complex with HEPES | monomer | 3×EDO; | 6ywk | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 (Covid-19) NSP3 macrodomain in complex with ADP-ribose | monomer | 1×APR; 6×EDO; | 6ywl | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000016052862 | monomer | 1×LZ1; | 5rvr | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000154817 | monomer | 1×1SQ; | 5rvp | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000002508153 | monomer | 1×4BY; | 5rvq | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000001612349 | monomer | 1×4JQ; | 5rvj | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000002506130 | monomer | 1×6P3; | 5rvu | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000332748 | monomer | 1×ANN; | 5rvn | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000002582714 | monomer | 1×4BL; | 5rvt | ||
| Assess | |||||
| Crystal Structure of ADP ribose phosphatase of NSP3 from SARS-CoV-2 in the apo form | monomer | 1×CL; | 6wen | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000149580 | monomer | 1×BVF; | 5rvl | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000020269197 | monomer | 1×WB1; | 5rvv | ||
| Assess | |||||
| Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2 in complex with AMP | monomer | 1×AMP; | 6w6y | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000002977810 | monomer | 1×2AK; | 5rvk | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000159004 | monomer | 1×0LO; | 5rvs | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000013514509 | monomer | 1×AQO; | 5rvo | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain (C2 crystal form, 310 K) | monomer | 7kr1 | |||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain (P43 crystal form) | monomer | 7kqo | |||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ADP-ribose (P43 crystal form) | monomer | 1×AR6; | 7kqp | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000084843283 | monomer | 1×CLW; | 5rvi | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000265642 | monomer | 1×Q3C; | 5rvh | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W2S; | 5s3w | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000158540 | monomer | 1×0HN; | 5rv6 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000365052868 | monomer | 1×W51; | 5rsl | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000014419577 | monomer | 1×7PD; | 5rvb | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000001674697 | monomer | 1×W4S; | 5rsb | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000002582714 | monomer | 1×4BL; | 5rt0 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000388514 | monomer | 1×2CL; | 5ru0 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000039994 | monomer | 1×W6V; | 5rv0 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000005878 | monomer | 1×NCA; | 5ruc | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000933940912 | monomer | 1×W7V; | 5rvc | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000008861082 | monomer | 1×52F; | 5rum | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000002005 | monomer | 1×PZA; | 5rtm | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000001688638 | monomer | 1×6V9; | 5ru4 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000064576 | monomer | 1×51X; | 5rsn | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000013514509 | monomer | 1×AQO; | 5rtn | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000194295 | monomer | 1×EXB; | 5run | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000388081 | monomer | 1×HSM; | 5rus | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000404062 | monomer | 1×FHB; | 5rtz | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000019685960 | monomer | 1×W6S; | 5ruz | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000337835 | monomer | 1×6FZ; | 5rsw | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000016989831 | monomer | 1×54T; | 5ruf | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000026180281 | monomer | 1×W5M; | 5rsf | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000002047514 | monomer | 1×ISN; | 5rtf | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000034618676 | monomer | 1×W4Y; | 5rs7 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000015442276 | monomer | 1×GVH; | 5rt7 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000003591110 | monomer | 1×PYD; | 5ru7 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000003954002 | monomer | 1×JNZ; | 5rv7 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000082473428_N3 | monomer | 1×W8D; | 5rvf | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000332540 | monomer | 1×Q6T; | 5rta | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000001698894 | monomer | 1×PF0; 1×DMS; | 5rtv | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000019015194 | monomer | 1×W6J; | 5ruv | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000332651 | monomer | 1×4YS; | 5rui | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000164777 | monomer | 1×OHP; | 5rtw | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000045014941 | monomer | 1×W6M; | 5ruw | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000154817 | monomer | 1×1SQ; | 5ru8 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000039575 | monomer | 1×8EJ; | 5rv8 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000388056 | monomer | 1×4J8; | 5rtl | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000163774 | monomer | 1×5ZE; | 5rul | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000158490 | monomer | 1×MOK; | 5rsq | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000019015078 | monomer | 1×4JO; | 5rtq | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000159056 | monomer | 1×1FF; | 5rtu | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000158650 | monomer | 1×XIY; | 5rsr | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000018169763 | monomer | 1×SHA; | 5rtr | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000017744334 | monomer | 1×FBB; | 5rur | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000161696 | monomer | 1×8H8; | 5ru3 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000331945 | monomer | 1×1LQ; | 5rsd | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000008615114 | monomer | 1×2D0; | 5rud | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000263980802 | monomer | 1×W7Y; | 5rvd | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000736709772 | monomer | 1×W8A; | 5rve | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000336438345 | monomer | 1×W5P; | 5rse | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000013283576 | monomer | 1×4FL; | 5rte | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000032199226 | monomer | 1×W6D; | 5ruq | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000156509 | monomer | 1×05R; 1×DMS; | 5rt6 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000001442764 | monomer | 1×2UP; | 5ru6 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000039224 | monomer | 1×4FS; | 5rv4 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000002055 | monomer | 1×OHB; | 5rsu | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000013517187 | monomer | 1×XAN; | 5ruy | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000157088 | monomer | 1×HBD; | 5rty | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000089254160_N3 | monomer | 1×W5A; | 5rsj | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000332752 | monomer | 1×PHB; | 5rtj | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000156863 | monomer | 1×3BZ; | 5rth | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000123600 | monomer | 1×KNL; | 5ruh | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000274438208 | monomer | 1×W5G; | 5rsh | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000165882 | monomer | 1×4SV; | 5ru9 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000388150 | monomer | 1×EKZ; | 5rv9 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000007636250 | monomer | 1×W4V; | 5rs9 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000006691828 | monomer | 1×NC3; | 5rss | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000159004 | monomer | 1×0LO; | 5rts | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000332673 | monomer | 1×5HN; | 5rst | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000873830 | monomer | 1×NMI; | 5rtt | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000161958 | monomer | 1×APG; | 5rut | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000033986325 | monomer | 1×3EU; 1×DMS; | 5rua | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000016343276 | monomer | 1×HQD; | 5rva | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000901381520_N3 | monomer | 1×W57; | 5rsk | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000164504 | monomer | 1×BZX; | 5rtk | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000008652361 | monomer | 1×5OF; | 5rt2 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000331715 | monomer | 1×06Y; | 5ru2 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000388302 | monomer | 1×4PN; | 5rto | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000001683100 | monomer | 1×W6A; | 5ruo | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000001679336 | monomer | 1×AOT; | 5rtp | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000004976927 | monomer | 1×04R; | 5rup | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000039810 | monomer | 1×3A9; | 5rt1 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000034687 | monomer | 1×DFA; | 5ru1 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000251609 | monomer | 1×TFA; | 5rv1 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000058111 | monomer | 1×07L; | 5rt5 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000098208711 | monomer | 1×BXW; | 5ru5 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000008578948 | monomer | 1×JG8; | 5rv5 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000161908 | monomer | 1×HLR; | 5rt8 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000038389 | monomer | 1×NOA; | 5rug | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000400552187_N3 | monomer | 2×W8J; | 5rvg | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000263392672 | monomer | 1×W5J; | 5rsg | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000388262 | monomer | 1×YTX; 1×DMS; | 5rsx | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000090873 | monomer | 1×6OT; | 5rtx | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000002020050 | monomer | 1×W6P; | 5rux | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000404314 | monomer | 1×2SX; | 5ruj | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000311783 | monomer | 1×W7S; | 5rv2 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000374420934 | monomer | 1×W5D; | 5rsi | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000004219237 | monomer | 1×6U6; | 5rti | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000438614 | monomer | 1×W6G; | 5ruu | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000388280 | monomer | 1×54G; 1×DMS; | 5rt9 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000003888754 | monomer | 1×W5S; | 5rsc | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000001601 | monomer | 1×H35; | 5rs8 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000395673 | monomer | 1×3HP; | 5rtg | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 3×W3J; 2×DMS; | 5s4c | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000001099 | monomer | 1×4SO; | 5rsm | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000051581 | monomer | 1×4BX; | 5rt4 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000004218283 | monomer | 1×ZZA; | 5rsz | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000057162 | monomer | 1×MYI; | 5rv3 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000000922 | monomer | 1×BHA; | 5rue | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000002560357 | monomer | 1×LSA; | 5rsp | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000340465 | monomer | 1×4MB; | 5rsv | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000000226 | monomer | 1×TYZ; | 5rso | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×VXD; | 5s2u | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W24; | 5s3r | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000006534965 | monomer | 1×3XH; | 5rtb | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000157108 | monomer | 1×MHW; | 5rtd | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000004787230 | monomer | 1×3R6; | 5rsy | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000039281982 | monomer | 1×2FX; | 5rt3 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000161692 | monomer | 1×NVU; | 5ruk | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W0M; | 5s2y | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000006490906 | monomer | 1×EVE; | 5rtc | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W0J; | 5s2x | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×U0P; | 5s2d | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×VWV; | 5s2h | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W44; | 5s4k | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W0G; | 5s2v | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×LUY; | 5s2i | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×UUJ; | 5s43 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×JGG; | 5s2j | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W2Y; | 5s3y | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W2M; | 5s3v | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WSM; | 5s27 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W0S; | 5s31 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W1P; | 5s3i | ||
| Assess | |||||
| Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2 | monomer | 2×SO4; 1×NHE; | 6vxs | ||
| Assess | |||||
| Crystal Structure of ADP ribose phosphatase of NSP3 from SARS-CoV-2 in complex with MES | monomer | 2×MES; | 6wcf | ||
| Assess | |||||
| Structure of the SARS-CoV-2 NSP3 Macro X domain in complex with cyclic AMP | monomer | 1×CMP; | 7jme | ||
| Assess | |||||
| PanDDA analysis group deposition of ground-state model of SARS-CoV-2 Nsp3 macrodomain | monomer | 2×EDO; | 5s74 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 2×3TR; 1×DMS; | 5s49 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W04; | 5s2p | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WRD; | 5s20 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W27; | 5s3s | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WSY; 1×DMS; | 5s3e | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×GOV; 1×DMS; | 5s34 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×7ZC; | 5s36 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W3A; | 5s44 | ||
| Assess | |||||
| PanDDA analysis group deposition of ground-state model of SARS-CoV-2 Nsp3 macrodomain | monomer | 5s73 | |||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×K2G; | 5s33 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WQ4; 1×DMS; | 5s1i | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×T6J; | 5s2z | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×DMS; 2×W3M; | 5s4e | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×S7J; | 5s38 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×HRZ; 1×DMS; | 5s48 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WQ7; | 5s1k | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W2J; | 5s3u | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WPS; | 5s1a | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WS4; | 5s2a | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WQM; 1×DMS; | 5s1u | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×4AP; | 5s4a | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×GWP; 1×CL; | 5s2w | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W2G; 1×DMS; | 5s3t | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×VZS; | 5s2l | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WQA; 1×DMS; | 5s1o | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 2×BAQ; | 5s47 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WRV; | 5s28 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×HH8; 1×DMS; | 5s42 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W1A; | 5s3b | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WQY; | 5s1y | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×NXS; | 5s2o | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×JH4; | 5s3l | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WSJ; | 5s2c | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×VZP; | 5s2k | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×B1A; | 5s35 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W21; | 5s3p | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×GWV; | 5s2s | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W0D; | 5s2t | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WSG; | 5s2b | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WQ1; | 5s1g | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×VZM; | 5s2e | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W41; | 5s4j | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×L46; | 5s26 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WQG; | 5s1q | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W2V; | 5s3x | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WOY; 1×DMS; | 5s18 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W3Y; | 5s4i | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W3P; 1×SO4; | 5s4f | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×K41; | 5s2r | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×GWY; | 5s2n | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WQV; | 5s1w | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×VZY; | 5s2m | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×JHS; | 5s3g | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WRM; | 5s24 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W3D; | 5s45 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WQJ; | 5s1s | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W1J; 1×DMS; | 5s3f | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W0Y; 1×DMS; | 5s39 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×RZS; 1×NHE; | 5s3k | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W3S; 1×SO4; | 5s4g | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WPY; 1×DMS; | 5s1e | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WPV; 1×DMS; | 5s1c | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WRJ; | 5s22 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W3V; | 5s4h | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W17; 1×DMS; | 5s3a | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×DE5; | 5s1m | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W3G; 1×DMS; | 5s4b | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W1V; | 5s3n | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W1D; 2×DMS; | 5s3c | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×HGQ; | 5s41 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 2×K0G; | 5s2f | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×HHQ; | 5s40 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W1Y; | 5s3o | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W1M; | 5s3h | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W0P; | 5s30 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×JHJ; | 5s2g | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×HYN; | 5s46 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×NZ1; | 5s37 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×2OP; 1×LAC; 1×DMS; | 5s4d | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W0A; | 5s2q | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×WRY; | 5s29 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W34; | 5s3z | ||
| Assess | |||||
| Crystal structure of CoV-2 Nsp3 Macrodomain | monomer | 2×MLI; 1×MES; 1×GOL; 3×SO4; | 7kg3 | ||
| Assess | |||||
| Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2 in the complex with ADP ribose | monomer | 1×APR; 1×EDO; | 6w02 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W1S; | 5s3j | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W2A; | 5s3q | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×W0V; | 5s32 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×JFP; 2×DMS; | 5s3d | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 Nsp3 macrodomain in complex wit… | monomer | 1×S2S; | 5s3m | ||
| Assess | |||||
| Oligo-state | Ligands | QMEAN | Template | Range | Seq id (%) |
|---|---|---|---|---|---|
| monomer | -0.41 | 2w2g.1.A | 75.00 | ||
| Assess | |||||
| monomer | -1.76 | 2kqv.1.A | 78.13 | ||
| Assess | |||||
| monomer | -0.78 | 2k87.1.A | 81.74 | ||
| Assess | |||||
| monomer | -1.10 | 2kqw.1.A | 80.22 | ||
| Assess | |||||
Non-structural protein 4 2764-3263; PRO_0000449622
| Oligo-state | Ligands | QMEAN | Template | Range | Seq id (%) |
|---|---|---|---|---|---|
| homo-2-mer | -1.47 | 3vcb.1.A | 61.36 | ||
| Assess | |||||
3C-like proteinase 3264-3569; PRO_0000449623
| Description | Oligo-state | Ligands | Structure | Range | |
|---|---|---|---|---|---|
| SARS-CoV-2 Main protease C145S mutant in complex with N and C-terminal residues |
Heteromer | 7kvg | |||
| Assess | |||||
| Crystal Structure of SARS-CoV-2 Main Protease (3CLpro/Mpro) in the Apo Form at 1.2 A Resolution | homo-2-mer | 22×DMS; | 7k3t | ||
| Assess | |||||
| SARS-CoV-2 main protease with unliganded active site (2019-nCoV, coronavirus disease 2019, COVID-19… | homo-2-mer | 16×DMS; | 6yb7 | ||
| Assess | |||||
| THE 1.28A CRYSTAL STRUCTURE OF 3CL MAINPRO OF SARS-COV-2 WITH OXIDIZED C145 (sulfinic acid cysteine) | homo-2-mer | 4×EDO; 8×FMT; 2×ACT; | 6xkh | ||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to Tegafur | homo-2-mer | 2×S7W; 8×DMS; | 7awr | ||
| Assess | |||||
| Crystal Structure of SARS-CoV-2 Main Protease (3CLpro/Mpro) in Complex with Covalent Inhibitor Boce… | homo-2-mer | 2×U5G; 10×DMS; | 7k40 | ||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to Pelitinib | homo-2-mer | 8×DMS; 2×93J; 2×IMD; | 7axm | ||
| Assess | |||||
| Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI5 | homo-2-mer | 2×VHM; | 7jq2 | ||
| Assess | |||||
| X-ray Structure of SARS-CoV-2 main protease bound to Boceprevir at 1.45 A | homo-2-mer | 2×U5G; | 6wnp | ||
| Assess | |||||
| SARS-CoV-2 Main Protease in mature form | homo-2-mer | 7kph | |||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to Isofloxythepin | homo-2-mer | 4×S8T; 6×DMS; 2×IMD; 2×PEG; | 7ay7 | ||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to AZD6482. | homo-2-mer | 2×A82; 4×CL; 8×DMS; 6×PEG; 2×CA; | 6yvf | ||
| Assess | |||||
| The crystal structure of COVID-19 main protease in complex with carmofur | homo-2-mer | 2×JRY; 10×DMS; | 7buy | ||
| Assess | |||||
| Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI1 | homo-2-mer | 2×GHX; | 7jpz | ||
| Assess | |||||
| Crystal structure of the SARS-CoV-2 main protease in its apo-form | homo-2-mer | 7jpy | |||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to Tretazicar. | homo-2-mer | 2×CB1; 10×DMS; 4×CL; | 7ak4 | ||
| Assess | |||||
| Crystal structure of the main protease (3CLpro/Mpro) of SARS-CoV-2 at 1.65A resolution (spacegroup … | homo-2-mer | 7ali | |||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to Tofogliflozin. | homo-2-mer | 2×RT2; 10×DMS; 4×CL; | 7aph | ||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to AR-42. | homo-2-mer | 10×DMS; 2×QCP; | 7axo | ||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to Clonidine | homo-2-mer | 2×CLU; 14×DMS; | 7aww | ||
| Assess | |||||
| Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI4 | homo-2-mer | 2×VHJ; | 7jq1 | ||
| Assess | |||||
| Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI3 | homo-2-mer | 2×VHV; | 7jq0 | ||
| Assess | |||||
| Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI7 | homo-2-mer | 2×XM2; | 7jq4 | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 Mpro in complex with the activity-based probe, biotin-PEG(4)-Abu-Tl… | homo-2-mer | 2×Q5T; 4×CL; 2×NA; | 6z2e | ||
| Assess | |||||
| Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor UAW248 | homo-2-mer | 2×GOL; 1×NA; 1×DMS; | 6xbi | ||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to Ipidacrine. | homo-2-mer | 4×DMS; 2×CL; 2×R9W; | 7af0 | ||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to Adrafinil. | homo-2-mer | 8×DMS; 2×RNW; | 7ans | ||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to Ifenprodil | homo-2-mer | 2×QEL; 4×DMS; 4×IMD; | 7aqi | ||
| Assess | |||||
| Crystal structure of the SARS-CoV-2 main protease in complex with Telaprevir | homo-2-mer | 1×SV6; 2×CL; 1×FK3; | 7c7p | ||
| Assess | |||||
| Crystal structure of the free enzyme of the SARS-CoV-2 (2019-nCoV) main protease | homo-2-mer | 6y2e | |||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to MUT056399. | homo-2-mer | 2×RQN; | 7ap6 | ||
| Assess | |||||
| Crystal Structure of SARS-CoV-2 Main Protease (3CLpro/Mpro) in Complex with Covalent Inhibitor Narl… | homo-2-mer | 2×NNA; 8×DMS; 2×NA; | 7jyc | ||
| Assess | |||||
| Room temperature X-ray crystallography reveals catalytic cysteine in the SARS-CoV-2 3CL Mpro is hig… | homo-2-mer | 2×DMS; | 6xb0 | ||
| Assess | |||||
| Room temperature X-ray crystallography reveals oxidation and reactivity of cysteine residues in SAR… | homo-2-mer | 6xhu | |||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to 2-Methyl-1-tetralone. | homo-2-mer | 2×P6N; 2×DMS; 2×CL; | 6ynq | ||
| Assess | |||||
| Room temperature X-ray crystallography reveals catalytic cysteine in the SARS-CoV-2 3CL Mpro is hig… | homo-2-mer | 2×NEN; | 6xb1 | ||
| Assess | |||||
| The crystal structure of 3CL MainPro of SARS-CoV-2 with oxidized Cys145 (Sulfenic acid cysteine). | homo-2-mer | 2×EDO; 1×CL; | 6xkf | ||
| Assess | |||||
| Structure of wild-type substrate free SARS-CoV-2 Mpro. | homo-2-mer | 7jp1 | |||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to SEN1269 ligand | homo-2-mer | 2×CL; 1×S1W; | 7avd | ||
| Assess | |||||
| Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication | homo-2-mer | 6wtm | |||
| Assess | |||||
| Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication | homo-2-mer | 2×K36; | 6wtj | ||
| Assess | |||||
| Ambient-Temperature Serial Femtosecond X-ray Crystal structure of SARS-CoV-2 Main Protease at 1.9 A… | homo-2-mer | 7cwb | |||
| Assess | |||||
| Room-temperature X-ray Crystal structure of SARS-CoV-2 main protease in complex with Telaprevir | homo-2-mer | 2×SV6; | 6xqs | ||
| Assess | |||||
| Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI8 | homo-2-mer | 2×NOL; | 7jq5 | ||
| Assess | |||||
| Acyl-enzyme intermediate structure of SARS-CoV-2 Mpro in complex with its C-terminal autoprocessing… | homo-2-mer | 3×DMS; | 7khp | ||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to Glutathione isopropyl ester | homo-2-mer | 2×S8H; 4×DMS; 2×IMD; | 7ax6 | ||
| Assess | |||||
| The crystal structure of COVID-19 main protease in apo form | homo-2-mer | 6m03 | |||
| Assess | |||||
| Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication | homo-2-mer | 2×UED; | 6wtk | ||
| Assess | |||||
| Product structure of SARS-CoV-2 Mpro C145A mutant in complex with its C-terminal autoprocessing seq… | homo-2-mer | 7joy | |||
| Assess | |||||
| Complex Structure of SARS-CoV-2 3CL Protease with TG-0205221 | homo-2-mer | 2×NOL; | 7c8t | ||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to LSN2463359. | homo-2-mer | 2×S8B; 2×CL; | 7awu | ||
| Assess | |||||
| The crystal structure of 3CL MainPro of SARS-CoV-2 with C145S mutation | homo-2-mer | 1×EDO; | 6xoa | ||
| Assess | |||||
| Room temperature X-ray crystallography reveals catalytic cysteine in the SARS-CoV-2 3CL Mpro is hig… | homo-2-mer | 4×NEN; 2×DMS; | 6xb2 | ||
| Assess | |||||
| Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI6 | homo-2-mer | 2×VHP; | 7jq3 | ||
| Assess | |||||
| The crystal structure of COVID-19 main protease in complex with an inhibitor N3 | homo-2-mer | 6lu7 | |||
| Assess | |||||
| SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor | homo-2-mer | 2×3WL; | 6m2n | ||
| Assess | |||||
| Room-temperature X-ray Crystal structure of SARS-CoV-2 main protease in complex with Leupeptin | homo-2-mer | 6xch | |||
| Assess | |||||
| Room-temperature X-ray Crystal structure of SARS-CoV-2 main protease in complex with Boceprevir | homo-2-mer | 2×U5G; | 6xqu | ||
| Assess | |||||
| Complex Structure of SARS-CoV-2 3CL Protease with TG-0203770 | homo-2-mer | 2×TG3; | 7c8r | ||
| Assess | |||||
| Structural Plasticity of the SARS-CoV-2 3CL Mpro Active Site Cavity Revealed by Room Temperature X-… | homo-2-mer | 6wqf | |||
| Assess | |||||
| Room-temperature X-ray Crystal structure of SARS-CoV-2 main protease in complex with Narlaprevir | homo-2-mer | 2×NNA; | 6xqt | ||
| Assess | |||||
| SARS CoV-2 MAIN PROTEASE 3CLpro, ROOM TEMPERATURE, DAMAGE FREE XFEL MONOCLINIC STRUCTURE | homo-2-mer | 7jvz | |||
| Assess | |||||
| Joint neutron/X-ray structure of SARS-CoV-2 3CL Mpro at room temperature | homo-2-mer | 7jun | |||
| Assess | |||||
| CRYSTAL STRUCTURE OF THE SARS-CoV-2 MAIN PROTEASE COMPLEXED WITH GC376 | homo-2-mer | 2×K36; 1×DMS; | 7d1m | ||
| Assess | |||||
| Structure of apo SARS-CoV-2 Main Protease with small beta angle, space group C2. | homo-2-mer | 10×DMS; | 7ar5 | ||
| Assess | |||||
| Structure of apo SARS-CoV-2 Main Protease with large beta angle, space group C2. | homo-2-mer | 2×CL; 12×DMS; | 7ar6 | ||
| Assess | |||||
| X-ray Structure of SARS-CoV-2 main protease bound to GRL-024-20 at 1.45 A | homo-2-mer | 2×V7G; | 6xr3 | ||
| Assess | |||||
| SARS-CoV-2 Main Protease Co-Crystal Structure with Telaprevir Determined from Crystals Grown with 4… | homo-2-mer | 2×DMS; 2×SV6; | 7k6d | ||
| Assess | |||||
| The crystal structure of 3CL MainPro of SARS-CoV-2 with de-oxidized C145 | homo-2-mer | 4×EDO; 4×FMT; | 7jfq | ||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to PD 168568. | homo-2-mer | 2×CL; 14×DMS; 2×RMZ; | 7amj | ||
| Assess | |||||
| SARS-CoV-2 Main Protease Co-Crystal Structure with Telaprevir Determined from Crystals Grown with 4… | homo-2-mer | 2×DMS; 2×SV6; | 7k6e | ||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to 2,4'-Dimethylpropiophenone. | homo-2-mer | 8×DMS; 2×R7Q; 2×IMD; 2×CL; | 7adw | ||
| Assess | |||||
| Crystal structure of the main protease (3CLpro/Mpro) of SARS-CoV-2 at 1.65A resolution (spacegroup … | homo-2-mer | 7alh | |||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to Fusidic Acid. | homo-2-mer | 2×FUA; 10×DMS; 4×IMD; | 7a1u | ||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to AT7519 | homo-2-mer | 2×LZE; 4×CL; 16×DMS; | 7aga | ||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to Maleate. | homo-2-mer | 4×CL; 12×DMS; 2×SIN; | 7aha | ||
| Assess | |||||
| SARS-CoV-2 3CL protease (3CL pro) apo structure (space group C21) | homo-2-mer | 6m2q | |||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to TH-302. | homo-2-mer | 2×S8E; 10×DMS; 2×CL; | 7aws | ||
| Assess | |||||
| Crystal structure (monoclinic form) of the complex resulting from the reaction between SARS-CoV-2 (… | homo-2-mer | 2×DMS; 2×O6K; | 6y2f | ||
| Assess | |||||
| Crystal structure of SARS-CoV-2 main protease in complex with MI-23 | homo-2-mer | 2×GQU; 2×TRS; | 7d3i | ||
| Assess | |||||
| Structure of COVID-19 main protease bound to potent broad-spectrum non-covalent inhibitor X77 | homo-2-mer | 2×X77; | 6w63 | ||
| Assess | |||||
| Crystal structure of the SARS-CoV-2 main protease in complex with Boceprevir (space group P212121) | homo-2-mer | 2×U5G; | 7com | ||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to Calpeptin. | homo-2-mer | 2×RN2; 2×CL; | 7aku | ||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to Triglycidyl isocyanurate. | homo-2-mer | 2×S7H; 2×RV8; | 7aqj | ||
| Assess | |||||
| PanDDA analysis group deposition of ground-state model of SARS-CoV-2 main protease screened against… | homo-2-mer | 6×DMS; | 5r8t | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of COVID-19 main protease in complex with Z21… | homo-2-mer | 2×RZS; 8×DMS; | 5r82 | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 2×UHG; 10×DMS; | 5rh4 | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 6×DMS; 2×U0S; | 5rgj | ||
| Assess | |||||
| SARS-CoV-2 main protease with unliganded active site (2019-nCoV, coronavirus disease 2019, COVID-19) | homo-2-mer | 8×DMS; | 6y84 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×K1Y; | 5rfc | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 4×DMS; 4×K1G; | 5rgr | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×T6J; | 5rfd | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 6×DMS; 2×U0V; | 5rgk | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 8×DMS; 2×T8M; | 5rfw | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 2×UGM; 8×DMS; | 5rgw | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 10×DMS; 2×USD; | 5rhb | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×S7D; | 5rf9 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×SFY; | 5rf8 | ||
| Assess | |||||
| Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor UAW246 | homo-2-mer | 3×GOL; 1×NA; | 6xbg | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 8×DMS; 2×NTG; | 5rf6 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×JGG; | 5rfe | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×JJG; | 5red | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×K3S; | 5rfb | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T8J; | 5rfv | ||
| Assess | |||||
| PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhi… | homo-2-mer | 2×VEM; 8×DMS; | 5rl2 | ||
| Assess | |||||
| The crystal structure of SARS-CoV-2 Main Protease with the formation of Cys145-1H-indole-5-carboxyl… | homo-2-mer | 2×XC4; 2×EDO; | 7kyu | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×T5V; | 5rf3 | ||
| Assess | |||||
| The crystal structure of COVID-19 main protease in complex with an inhibitor 11b | homo-2-mer | 8×DMS; 2×FJC; | 6m0k | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 2×T8M; 8×DMS; | 5rha | ||
| Assess | |||||
| PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhi… | homo-2-mer | 8×DMS; 2×VEP; | 5rl3 | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 2×UH1; 8×DMS; | 5rgz | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 8×DMS; 2×T8D; | 5rfu | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×HVB; | 5rf2 | ||
| Assess | |||||
| PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhi… | homo-2-mer | 8×DMS; 2×VEV; | 5rl4 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×T67; | 5rf7 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T4M; | 5rew | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T8P; | 5rfx | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 2×UPD; 10×DMS; | 5rhe | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 14×DMS; 2×US7; | 5rhd | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 6×DMS; 2×U0P; | 5rgi | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 2×USA; 12×DMS; | 5rhc | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×K0G; | 5r83 | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 10×DMS; 2×T9P; | 5rg3 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T8A; | 5rft | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T6Y; | 5rfh | ||
| Assess | |||||
| PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhi… | homo-2-mer | 8×DMS; 2×VEY; | 5rl5 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 8×DMS; 2×HWH; | 5r7z | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T4J; | 5rev | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 8×DMS; 2×UHY; | 5rh6 | ||
| Assess | |||||
| Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor UAW247 | homo-2-mer | 2×GOL; 2×NA; | 6xbh | ||
| Assess | |||||
| The crystal structure of SARS-CoV-2 Main Protease in complex with masitinib | homo-2-mer | 2×G65; 2×DMS; 4×GOL; | 7ju7 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×T5Y; | 5rf4 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×6SU; | 5ref | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T2G; | 5rel | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×JGP; | 5rea | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 8×DMS; 2×T9M; | 5rg2 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T7G; | 5rfl | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of COVID-19 main protease in complex with Z45… | homo-2-mer | 2×JFM; 8×DMS; 2×CL; | 5r7y | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T5D; | 5rf0 | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 6×DMS; 2×T9J; | 5rg1 | ||
| Assess | |||||
| Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with UAW241 | homo-2-mer | 2×GOL; | 6xa4 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T3V; | 5res | ||
| Assess | |||||
| PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhi… | homo-2-mer | 2×VEJ; 8×DMS; | 5rl1 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×LWA; | 5reg | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×T0Y; | 5reb | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 10×DMS; 2×T8V; | 5rfz | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 8×DMS; 2×T47; | 5ret | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 8×DMS; 2×T4D; | 5reu | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 2×UHA; 6×DMS; | 5rh3 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T71; | 5rfi | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 2×UGP; 8×DMS; | 5rgx | ||
| Assess | |||||
| PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhi… | homo-2-mer | 2×VEG; 10×DMS; | 5rl0 | ||
| Assess | |||||
| Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with UAW243 | homo-2-mer | 2×GOL; | 6xfn | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 8×DMS; 2×U0M; | 5rgh | ||
| Assess | |||||
| Structure of the hemiacetal complex between the SARS-CoV-2 Main Protease and Leupeptin | homo-2-mer | 6×DMS; 2×IMD; 2×CL; | 6yz6 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 8×DMS; 2×T84; | 5rfs | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 8×DMS; 2×UJ1; | 5rh7 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T81; | 5rfr | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 8×DMS; 2×T8Y; | 5rg0 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 8×DMS; 2×T1V; | 5rej | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 2×UHV; 8×DMS; | 5rh5 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 10×DMS; 2×LPZ; | 5re9 | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 6×DMS; 2×S7V; | 5rgs | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 8×DMS; 2×T1J; | 5rec | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with N… | homo-2-mer | 8×DMS; 2×T5G; | 5rf1 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×HV2; | 5rf5 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T1Y; | 5rek | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 6×DMS; 2×U1G; | 5rgo | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T7D; | 5rfk | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 8×DMS; 2×T7Y; | 5rfq | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 8×DMS; 2×U0Y; | 5rgl | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 8×DMS; 2×UPJ; | 5rhf | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×T1M; | 5ree | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T6M; | 5rff | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T54; | 5rez | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 8×DMS; 2×T0S; | 5re7 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T7P; | 5rfn | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T7A; | 5rfj | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 8×DMS; 2×AWP; | 5reh | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 8×DMS; 2×UHM; | 5rh8 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×T0V; | 5re8 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 8×DMS; 2×T3G; | 5rep | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 2×UGG; 8×DMS; | 5rgv | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×T1S; | 5rei | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 2×UH7; 8×DMS; | 5rh2 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T7S; | 5rfo | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of COVID-19 main protease in complex with Z31… | homo-2-mer | 2×GWS; 6×DMS; | 5r84 | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 8×DMS; 2×U1A; | 5rgn | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×O0S; | 5re6 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T2Y; | 5reo | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×SZY; | 5re4 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T3J; | 5rer | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T8S; | 5rfy | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 8×DMS; 2×UJ4; | 5rh9 | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 2×UH4; 8×DMS; | 5rh0 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×RZG; | 5r80 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of COVID-19 main protease in complex with Z13… | homo-2-mer | 2×RZJ; 8×DMS; | 5r81 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T2J; | 5rem | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T4Y; | 5rey | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 2×UGV; 8×DMS; | 5rh1 | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 2×UGS; 10×DMS; | 5rgy | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 8×DMS; 2×T7V; | 5rfp | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 6×DMS; 2×U1D; | 5rgm | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T7J; | 5rfm | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 6×DMS; 2×T0J; | 5re5 | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 8×DMS; 2×T4V; | 5rex | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 8×DMS; 2×U1M; | 5rgp | ||
| Assess | |||||
| Crystal structure of SARS CoV2 main protease in complex with inhibitor Telaprevir | homo-2-mer | 2×DMS; 2×SV6; | 6zrt | ||
| Assess | |||||
| Crystal structure of SARS CoV2 main protease in complex with inhibitor Boceprevir | homo-2-mer | 4×DMS; 2×U5G; | 6zru | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 2×UGD; 8×DMS; | 5rgu | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T2V; | 5ren | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 4×DMS; 2×U1V; | 5rgq | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 8×DMS; 2×UHS; | 5rgt | ||
| Assess | |||||
| PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of S… | homo-2-mer | 6×DMS; 2×NZD; | 5rgg | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with P… | homo-2-mer | 6×DMS; 2×T6V; | 5rfg | ||
| Assess | |||||
| The crystal structure of COVID-19 main protease in complex with an inhibitor 11a | homo-2-mer | 8×DMS; 2×FHR; | 6lze | ||
| Assess | |||||
| Crystal structure (orthorhombic form) of the complex resulting from the reaction between SARS-CoV-2… | homo-2-mer | 1×GLY; 2×O6K; | 6y2g | ||
| Assess | |||||
| Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with noncovalent inhibitor … | homo-2-mer | 2×X7V; 4×GOL; | 7kx5 | ||
| Assess | |||||
| Covalent complex of SARS-CoV-2 main protease with N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopy… | homo-2-mer | 2×V2M; 1×EDO; | 6xhm | ||
| Assess | |||||
| SARS-CoV-2 3CL protease with alternative conformation of the active site promoted by methylene-brid… | homo-2-mer | 6×DMS; | 7jr4 | ||
| Assess | |||||
| 1.70 A resolution structure of SARS-CoV-2 3CL protease in complex with inhibitor 7j | homo-2-mer | 2×QYS; 1×PG4; | 6xmk | ||
| Assess | |||||
| Structure of SARS-CoV-2 Main Protease bound to thioglucose. | homo-2-mer | 2×RVW; 4×DMS; 2×CL; | 7arf | ||
| Assess | |||||
| Crystals Structure of the SARS-CoV-2 (COVID-19) main protease with inhibitor GC-376 | homo-2-mer | 2×K36; 2×PEG; 2×GOL; 6×CL; 2×MG; | 6wtt | ||
| Assess | |||||
| Crystal Structure of SARS-CoV-2 main protease in complex with an inhibitor GRL-2420 | homo-2-mer | 2×V7G; 1×1PE; | 7jkv | ||
| Assess | |||||
| PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z… | homo-2-mer | 4×DMS; 2×JGY; | 5rfa | ||
| Assess | |||||